GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol

INTRODUCTION: Chronic pelvic pain (CPP) affects >1 million UK women. Annual healthcare costs are estimated at >£150 million. Proven interventions for CPP are limited, and treatment is often unsatisfactory. Gabapentin is increasingly prescribed due to reports of effectiveness in other chronic p...

Descripción completa

Detalles Bibliográficos
Autores principales: Horne, Andrew W, Critchley, Hilary O D, Doust, Ann, Fehr, Daniel, Wilson, John, Wu, Olivia, Jack, S, Porter, Maureen, Lewis, Steff, Bhattacharya, Siladitya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Reproductive Medicine, Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371581/
https://www.ncbi.nlm.nih.gov/pubmed/22685224
http://dx.doi.org/10.1136/bmjopen-2012-001297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371581/
https://www.ncbi.nlm.nih.gov/pubmed/22685224
http://dx.doi.org/10.1136/bmjopen-2012-001297

Ejemplares similares